Consonance Capital Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Consonance Capital Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-181,818	Closed	-$5K	–	26
2016 Q1	$5K	Sell	181,818 -755,698	-81%	-$2.53M	﹤0.01%	22
2015 Q4	$4.28M	Sell	937,516 -955,951	-50%	-$4.53M	0.57%	16
2015 Q3	$8.92M	Buy	1,893,467 +132,818	+8%	+$858K	1.25%	15
2015 Q2	$12.6M	Buy	1,760,649 +128,022	+8%	+$963K	1.27%	17
2015 Q1	$13.8M	Hold	1,632,627	–	–	1.26%	18
2014 Q4	$15.2M	Buy	1,632,627 +112,223	+7%	+$976K	1.96%	15
2014 Q3	$12.7M	Buy	1,520,404 +68,712	+5%	+$636K	1.74%	20
2014 Q2	$16.8M	Buy	1,451,692 +560,137	+63%	+$5.75M	2.5%	17
2014 Q1	$11.3M	Buy	+891,555	New	+$11.5M	1.68%	21

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Consonance Capital Management's DSCI Position: Q2 2016 in Review

Consonance Capital Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2016, closing a stake of 181,818 shares — an estimated $5K sold.

Consonance Capital Management first reported a position in DSCI in Q1 2014 and held it in 9 quarters. The position peaked at $16.8M in Q2 2014. 53 funds tracked by Wall St. Rank hold DSCI as of Q2 2016.

Consonance Capital Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2016 after selling out during the quarter.
Consonance Capital Management sold 181,818 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2016, an estimated $5K.
Consonance Capital Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 9 quarters.
Consonance Capital Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $16.8M in Q2 2014.
53 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2016.

Based on Consonance Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.